Global Cell Banking Outsourcing Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Cell Banking Outsourcing market size was valued at US$ 8357 million in 2024 and is forecast to a readjusted size of USD 24360 million by 2031 with a CAGR of 16.7% during review period.
A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.
North America is the largest Cell Banking Outsourcing market with about 38% market share. Europe is follower, accounting for about 22% market share.The key manufacturers are SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec, CordLife, Esperite, Reliance Life Sciences, Lifecell, Cryo-Cell, Toxikon, Goodwin Biotechnology, Texcell, Cryo Stemcell etc. Top 3 companies occupied about 13% market share.
This report is a detailed and comprehensive analysis for global Cell Banking Outsourcing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cell Banking Outsourcing market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cell Banking Outsourcing market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cell Banking Outsourcing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cell Banking Outsourcing market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cell Banking Outsourcing
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cell Banking Outsourcing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec, CordLife, Esperite, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cell Banking Outsourcing market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Stem Cell Banking
Non-stem Cell Banking
Market segment by Application
Cell Bank Storage
Bank Characterization and Testing
Cell Bank Preparation
Market segment by players, this report covers
SGS Life Sciences
Lonza
CCBC
Vcanbio
AMAG Pharmaceuticals
ViaCord
Thermo Fisher
Wuxi Apptec
CordLife
Esperite
Reliance Life Sciences
Lifecell
Cryo-Cell
Toxikon
Goodwin Biotechnology
Texcell
Cryo Stemcell
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cell Banking Outsourcing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell Banking Outsourcing, with revenue, gross margin, and global market share of Cell Banking Outsourcing from 2020 to 2025.
Chapter 3, the Cell Banking Outsourcing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cell Banking Outsourcing market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell Banking Outsourcing.
Chapter 13, to describe Cell Banking Outsourcing research findings and conclusion.